Categories
Business News

Cell Expansion Market History, Overview and Future Developments by 2024 Analysis and Forecast

The Cell Expansion Market report shows the competitive situation among the top manufacturers, with sales, revenue and market share and the market by type and application. The report deeply described by experts team and made full report on Cell Expansion Market with Forecasts 2024.

The Cell Expansion Market is projected to reach USD 26.0 Billion by 2024 from USD 12.7 Billion in 2019, at a CAGR of 15.4% during the forecast period.

Browse 192 Market Data Tables and 35 Figures spread through 171 Pages and in-depth TOC on “Cell Expansion Market Research Report” https://www.reportsnreports.com/contacts/requestsample.aspx?name=313419

#Key Players- Thermo Fisher Scientific, Inc. (US), Becton, Dickinson and Company (US), Terumo BCT (Japan), Merck KGaA (Germany), Danaher Corporation (US), MiltenyiBiotec (Germany), Lonza Group Ltd. (Switzerland), STEMCELL Technologies Inc. (Canada), GE Healthcare (US), and Corning, Inc. (US).

On the basis of products, the cell expansion market is segmented into consumables and instruments. Consumables are segmented into reagents, media, sera, and disposables. The instruments segment includes cell expansion supporting equipment, bioreactors, and automated cell expansion systems. In 2018, consumables accounted for the largest share of the cell expansion products market owing to the constant requirement for new reagents among end users and rising investments for R&D on cell-based therapies.

Inquire for DISCOUNT on “Cell Expansion Market by Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research), End User, and Region – Global Forecast to 2024” research report at https://www.reportsnreports.com/contacts/discount.aspx?name=313419

Based on cell type, the cell expansion market is segmented into human cells and animal cells. The human cells segment includes stem cells and differentiated cells. The stem cells segment is further classified into adult stem cells, ESCs, and iPSCs. These cells are used for therapeutic and research purposes. In 2018, the human cells segment accounted for the larger share of the cell expansion market majorly due to the increasing investments by public and private organizations for research on human cells, growing application areas of human stem cells, and the growing incidence of diseases such as cancer.

North America, which includes the US and Canada, accounted for the largest share of the cell expansion in 2018.The large share of this market segment can be attributed to the government funding for cancer research, increasing awareness regarding advanced treatment theories, and the strong presence of industry players in the region.

Order a copy of “Cell Expansion Market” research report at https://www.reportsnreports.com/purchase.aspx?name=313419

Breakdown of supply-side primary interviews, by company type, designation, and region:

  • By Company Type: Tier 1:70%, Tier 2:20%, and Tier 3:10%
  • By Designation: C-level:30%, Director-level:20%, and Others:50%
  • By Region: North America:35%, Europe:24%, Asia:25%, and the RoW: 16%

Explore more reports on Biotechnology Market at https://www.reportsnreports.com/market-research/biotechnology/